Improved quality of care and reduced healthcare costs at the end-of-life among older people with dementia who received palliative home care: A nationwide propensity score-matched decedent cohort study
Restricted accessResearch articleFirst published online October, 2021
Improved quality of care and reduced healthcare costs at the end-of-life among older people with dementia who received palliative home care: A nationwide propensity score-matched decedent cohort study
While palliative home care is advocated for people with dementia, evidence of its effectiveness is lacking.
Aim:
To evaluate the effects of palliative home care on quality and costs of end-of-life care for older people with dementia.
Design:
Decedent cohort study using linked nationwide administrative databases and propensity score matching.
Setting/participants:
All home-dwelling older people who died with dementia between 2010 and 2015 in Belgium (N = 23,670).
Exposure:
Receiving palliative home care support for the first time between 360 and 15 days before death.
Results:
Five thousand six hundred and thirty-seven (23.8%) received palliative home care support in the last 2 years of life, of whom 2918 received it for the first time between 360 and 15 days before death. Two thousand eight hundred and thirty-nine people who received support were matched to 2839 people who received usual care. After matching, those using palliative home care support, in the last 14 days of life, had lower risk of hospital admission (17.5% vs 50.5%; relative risk (RR) = 0.21), undergoing diagnostic testing (17.0% vs 53.6%; RR = 0.20) and receiving inappropriate medications, but were more likely to die at home (75.7% vs 32.6%; RR = 6.45) and to have primary care professional contacts (mean 11.7 vs mean 5.2), compared with those who did not. Further, they had lower mean total costs of care in the last 30 days of life (incremental cost:−€2129).
Conclusions:
Palliative home care use by home-dwelling older people with dementia is associated with improved quality and reduced costs of end-of-life care. Access remains low and should be increased.
Alzheimer’s Association. Alzheimer’s disease facts and figures: Alzheimer’s Association Report. Alzheimers Dement2019; 15: 321–387.
2.
Alzheimer Europe. Dementia in Europe yearbook 2019: estimating the prevalence of dementia in Europe. Luxembourg: Alzheimer Europe, 2020.
3.
Van den BlockL. The need for integrating palliative care in ageing and dementia policies. Eur J Public Health2014; 24(5): 704–705.
4.
van der SteenJTRadbruchLHertoghCMPM, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med2014; 28(3): 197–209.
5.
Worldwide Hospice Palliative Care Alliance. Palliative care and dementia statement – Worldwide Hospice Palliative Care Alliance. In: First WHO ministerial conference on global action against dementia, Geneva, 2015.
6.
SamusQMBlackBSBovenkampD, et al. Home is where the future is: the Bright Focus Foundation consensus panel on dementia care. Alzheimers Dement2018; 14(1): 104–114.
7.
FoxSFitzGeraldCHarrison DeningK, et al. Better palliative care for people with a dementia: summary of interdisciplinary workshop highlighting current gaps and recommendations for future research. BMC Palliat Care2017; 17(1): 9.
GomesBCalanzaniNGyselsM, et al. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care2013; 12(7): 1–13.
10.
MurphyEFroggattKConnollyS, et al. Palliative care interventions in advanced dementia. Cochrane Database Syst Rev2016; 12: CD011513.
11.
MirandaRBunnFLynchJ, et al. Palliative care for people with dementia living at home: a systematic review of interventions. Palliat Med2019; 33(7): 726–742.
12.
JonesDSPodolskySH.The history and fate of the gold standard. Lancet2015; 385(9977): 1502–1503.
13.
BothwellLEGreeneJAPodolskySH, et al. Assessing the gold standard—lessons from the history of RCTs. N Engl J Med2019; 374(22): 2175–2181.
14.
HernanMRobinsJ.Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol2016; 183(8): 758–764.
15.
PastorinoRDe VitoCMigliaraG, et al. Benefits and challenges of Big Data in healthcare: an overview of the European initiatives. Eur J Public Health2019; 29: 23–27.
16.
MurdochTBDetskyAS.The inevitable application of big data to health care. JAMA2013; 309(13): 1351–1352.
17.
MaetensABeernaertKDe SchreyeR, et al. Impact of palliative home care support on the quality and costs of care at the end of life: a population-level matched cohort study. BMJ Open2019; 9(1): 1–9.
18.
MaetensADe SchreyeRFaesK, et al. Using linked administrative and disease-specific databases to study end-of-life care on a population level. BMC Palliat Care2016; 15(1): 86.
19.
MaetensADeliensLVan den BlockL, et al. Are we evolving toward greater and earlier use of palliative home care support? A trend analysis using population-level data from 2010 to 2015. J Pain Symptom Manage2019; 58(1): 19-28.
20.
KringosDSBoermaWGWHutchinsonA, et al. Building primary care in a changing Europe: Case studies. Copenhagen: European Observatory on Health Systems and Policies, 2015.
21.
HouttekierDCohenJVan Den BlockL, et al. Involvement of palliative care services strongly predicts place of death in Belgium. J Palliat Med2010; 13(12): 1461–1468.
World Health Organization. International statistical classification of diseases and related health problems 10th revision, https://icd.who.int/browse10/2019/en (accessed 9 April 2020).
25.
De SchreyeRHouttekierDDeliensL, et al. Developing indicators of appropriate and inappropriate end-of-life care in people with Alzheimer’s disease, cancer or chronic obstructive pulmonary disease for population-level administrative databases: a RAND/UCLA appropriateness study. Palliat Med2017; 31(10): 932–945.
26.
De SchreyeRSmetsTDeliensL, et al. Appropriateness of end-of-life care in people dying with dementia: applying quality indicators on linked administrative databases. J Am Med Dir Assoc2020; 21(8): 1–9.
27.
GomesBCalanzaniNCurialeV, et al. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev2013; (6): CD007760.
28.
WigginsNDroneyJMohammedK, et al. Understanding the factors associated with patients with dementia achieving their preferred place of death: a retrospective cohort study. Age Ageing2019; 48(3): 433–439.
29.
MataqiMAslanpourZ.Factors influencing palliative care in advanced dementia: a systematic review. BMJ Support Palliat Care2020; 10(19): 145–156.
30.
DaviesNKlapwijkMSvan der SteenJT.Palliative care in dementia. In: Textbook of palliative care. Springer International Publishing, 2018, pp.1–23.
31.
MoganCLloyd-WilliamsMHarrison DeningK, et al. The facilitators and challenges of dying at home with dementia: a narrative synthesis. Palliat Med2018; 32(6): 1042–1054.
32.
ParsonsLS.Performing a 1: N case-control match on propensity score. Washington, DC: Ovation Research Group, 2004.
33.
HillHAKleinbaumD.Bias in observational studies. In: Encyclopedia of biostatistics, Online. John Wiley & Sons Limited, 2005, pp. 1–7.
34.
PereiraMJTayRYTanWS, et al. Integrated palliative homecare in advanced dementia: reduced healthcare utilisation and costs. BMJ Support Palliat Care2020; 1–9.
35.
HeinzeGJüniP.An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J2011; 32: 1704–1708.
36.
ErelMMarcusE-LDekeyser-GanzF.Barriers to palliative care for advanced dementia: a scoping review. Ann Palliat Med2017; 6(4): 365–379.
37.
FriedmanBVeaziePJChapmanBP, et al. Is personality associated with health care use by older adults?Milbank Quart2013; 91(3): 491–527.
38.
GozaloPPlotzkeMMorV, et al. Changes in medicare costs with the growth of hospice care in nursing homes. N Engl J Med2015; 372: 19.
39.
ConnollyAGaehlEMartinH, et al. Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health2011; 15(8): 978–984.
40.
AmjadHRothDLSheehanOC, et al. Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults. J Gen Int Med2018; 33: 1131–1138.
CarterGvan der SteenJTGalwayK, et al. General practitioners’ perceptions of the barriers and solutions to good-quality palliative care in dementia. Dementia2017; 16(1): 79–95.
43.
HorlaitMChambaereKPardonK, et al. What are the barriers faced by medical oncologists in initiating discussion of palliative care? A qualitative study in Flanders, Belgium. Support Care Cancer2016; 24(9): 3873–3881.
44.
LunneyJRLynnJFoleyDJ, et al. Patterns of functional decline at the end of life. JAMA2003; 289(18): 2387–2392.
45.
van der SteenJT. Dying with dementia: what we know after more than a decade of research. J Alzheimers Dis2010; 22(1): 37–55.
46.
van PaapJRMarianiEChattatR, et al. Identification of the palliative phase in people with dementia: a variety of opinions between healthcare professionals. BMC Palliat Care2015; 14: 56.
47.
MeeussenKVan den BlockLEchteldM, et al. Older people dying with dementia: a nationwide study. Int Psychogeriatrics2012; 24(10): 1581–1591.
48.
PendersYWHAlbersGDeliensL, et al. End-of-life care for people dying with dementia in general practice in Belgium, Italy and Spain: a cross-sectional, retrospective study. Geriatr Gerontol Int2017; 17(10): 1667–1676.
49.
MirandaRPendersYWHSmetsT, et al. Quality of primary palliative care for older people with mild and severe dementia: an international mortality follow-back study using quality indicators. Age Ageing2018; 47(6): 824–833.
50.
MidtbustMHAlnesREGjengedalE, et al. Perceived barriers and facilitators in providing palliative care for people with severe dementia: the healthcare professionals’ experiences. BMC Health Serv Res2018; 18(1): 709.
51.
SommerbakkRHaugenDFTjoraA, et al. Barriers to and facilitators for implementing quality improvements in palliative care – results from a qualitative interview study in Norway. BMC Palliat Care2016; 15: 61.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
